NoviaHealth LLC was founded in 2023 as a spin-off from Synbiotic Health. The company was created to be the ideation to launch partner company for health innovator brands. To achieve that goal, they provide turn-key contract development and manufacturing services to the health and nutrition markets, along with commercial scale probiotic concentrates and custom blends. These include the ecologically advanced probiotics iVS-1® and iVE-15®, as well as a diverse range of clinically documented and undocumented strain genera and species. NoviaHealth’s value proposition focuses on delivering the benefits that health innovator brands have been asking for in a service-first culture, including product concept ideation, co-development, custom formulations, and low minimum order quantities, all within a culture of operational transparency.
The NoviaHealth brand name was created to reflect a new way of thinking and a new way of operating. Novia is derived from the Latin word “novus”, meaning new, which reflects their constant pursuit of new ideas and original solutions. As an innovative, boutique CDMO, they will cater to their customers with the services they need most: complete support from ideation to launch, a high-performing portfolio of probiotics, and a very strong commitment to personalized service. Their products feature unique, precise, scientifically-validated probiotic and microbiome ingredients designed to support optimal health in every age group. They offer a full spectrum of proven probiotic strains that have clinical data and market awareness, as well as a wide selection of undocumented strains to meet all of your formulation needs. NoviaHealth offers first-class quality coupled with a premium service experience. Their business objective is to set a new Gold Standard in probiotics contract services, providing faster lead times, better service, and low MOQs.